Photodynamic therapy with verteporfin in paediatric and young adult patients: Long-term treatment results of choroidal neovascularisations

British Journal of Ophthalmology

Volumn 92, Issue 5, 2008, Pages 655-660

  Lipski, A ^a   Bornfeld B Jurklies, N ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; TRIAMCINOLONE ACETATE; VERTEPORFIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOROIDITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LONG TERM CARE; MALE; MYOPIA; OCULAR HISTOPLASMOSIS; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; SUBRETINAL NEOVASCULARIZATION; TOXOPLASMOSIS; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; CHILD; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FLUORESCENCE; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; MALE; MYOPIA; OPHTHALMOSCOPY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 43649092227     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.134429     Document Type: Article

References (39)

1. Spaide RF. Choroidal neovascularization in younger patients. Curr Opin Ophthalmol 1999;10:177-81.
2. Cohen SY, Laroche A, Leguen Y, et al. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996;103: 1241-4.
3. Lindblom B, Andersson. The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age. Ophthalmology 1998;105:1816-20.
4. Muller-Velten R, Michels S, Schmidt-Erfurth, et al. Photodynamic therapy: extended indication. Ophthalmologe 2003;100:384-90.
5. Mimouni KF, Bressler SB, Bressler NM. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in children. An J Ophthalmol 2003;135:900-2
6. Giansanti F, Virgili G, Varano M, et al. Photodynamic therapy for choroidal neovascularization in pediatric patients. Retina 2005;25:590-6.
7. Rosenfeld PJ, Saperstein DA, Bressler NM, et al. Verteporfin in Ocular Histoplasmosis Study Group. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study. Ophthalmology 2004;111:1725-33.
8. Gass JD, Wilkinson CP. Follow-up study of presumed ocular histoplasmosis. Trans An Acad Ophthalmol Otolaryngol 1972;76:672- 94.
9. Hawkins BS, Bressler NM, Bressler SB, et al. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9. Arch Ophthalmol 2004;122:1597-611.
10. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Arch Ophthalmol 1991;109:1109-14.
11. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol 1994;112:500-9.
12. Macular Photocoagulation Study Group. Five year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Arch Ophthalmol 1996;114:677.
13. Sickenberg M, Schmidt-Erfurth U, Miller JW, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000;118:327-36.
14. Wachtlin J, Heimann H, Behme T, et al. Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol 2003;241:899-906.
15. Wachtlin J, Wehner A, Heimann H, et al. Photodynamic treatment with verteporfin for patients with idiopathic choroidal neovascularization. Two-year results. Ophthalmologe 2004;101:489- 95.
16. Hernández-Rojas ML, Quiroz-Mercado H, Dalma-Weiszhausz J, et al. Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia. Retina 2007;27:707-12.
17. Chan WM, Lai TY, Liu DT, et al. Intravitreal bevacizumab (avastin) for myopic choroidal neovascularization. Six-month results of a prospective pilot study. Ophthalmology 2007;114:2190-6.
18. Schadlu R. Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisations secondary to the ocular histoplasmosis syndrome. IOVS 2007;48:E-Abstract 1458.
19. Chan WM, Lai TY, Liu DT, et al. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 2007;143:977-83.
20. O'Toole L, Tufail A, Pavesio C. Management of choroidal neovascularization in uveitis. Int Ophthalmol Clin 2005;45:157-77.
21. Blinder KJ, Blumenkranz MS, Bressler NM, et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP report no. 3. Ophthalmology 2003;110:667-73.
22. Virgili G, Varano M, Giacomelli G, et al. Photodynamic therapy for nonsubfoveal choroidal neovascularization in 100 eyes with pathologic myopia. Am J Ophthalmol 2007;143:77-82.
23. Gelisken F, Inhoffen W, Hermann A, et al. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation in pathologic myopia. Graefes Arch Clin Exp Ophthalmol 2004;242:926-30.
24. Azab M, Benchaboune M, Blinder KJ, et al. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2 year safety results in three randomized clinical trials: treatment of age-related macular degeneration with photodynamic therapy and verteporfin in photodynamic therapy study report no. 4. Retina 2004;24:1-12.
25. Jurklies B, Bornfeld N, Schilling H. Photodynamic therapy using verteporfin for choroidal neovascularization associated with angioid streaks-long-term effects. Ophthalmic Res 2006;38:209-17.
26. Jurklies B, Anastassiou G, Ortmans S, et al. Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma. Br J Ophthalmol 2003;87:84-9.
27. Chamberlin JA, Bressler NM, Bressler SB, et al. The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. Ophthalmology 1989;96:1526-34.
28. Voo MH, Boo HD, Kim HK. Result of photodynamic therapy for idiopathic subfoveal choroidal neovascularization. Korean J Ophthalmol 2005;19:264-8.
29. Rogers AH, Duker JS, Nichols N, et al. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology 2003;110:1315-20.
30. Busquets MA, Shah GK, Wickens J, et al. Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Retina 2003;23:299-306.
31. Spaide RF, Martin ML, Slakter J, et al. Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol 2002;134:62-8.
32. Spaide RF, Freund KB, Slakter J, et al. Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina 2002;22:545-9.
33. Gerth C, Spital G, Lommatzsch A, et al. Photodynamic therapy for choroidal neovascularization in patients with multifocal choroiditis and panuveitis. Eur J Ophthalmol 2006;16:111-8.
34. Mauget-Faysse M, Mimoun G, Ruiz-Moreno JM, et al. Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis. Retina 2006;26:396-403.
35. Liu JC, Boldt HC, Folk JC, et al. Photodynamic therapy of subfoveal and juxtafoveal choroidal neovascularization in ocular histoplasmosis syndrome: a retrospective case series. Retina 2004;24:863-70.
36. Harissi-Dagher M, Sebag M, Gauthier D, et al. Photodynamic therapy in young patients with choroidal neovascularization following traumatic choroidal rupture. Am J Ophthalmol 2005;139:726-8.
37. Haimovici R, Kramer M, Miller JW, et al. Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. Curr Eye Res 1997;16:83-90.
38. Schlotzer-Schrehardt U, Viestenz A, Naumann GO, et al. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol 2003;240:748-57.
39. Postelmans L, Pasteels B, Coquelet P, et al. Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females. Am J Ophthalmol 2004;138: 803-8.